Clinical Trial

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-03; most recent amendment 2026-07-23.
Status change: Recruiting → Active, Not Recruiting 2026-07-16
Status change: Not Yet Recruiting → Recruiting 2025-12-16
Trial Details
NCT Number NCT07286682
Lead Sponsor UCB Biopharma SRL
Conditions Healthy Participants
Enrollment 80 participants
Start Date 2025-12-08
Primary Completion 2026-12-13 (estimated)
Study Completion 2026-12-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-24